Price target
6.180.00 0.00%
The 4 analysts offering 1 year price forecasts for AXD2 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 4 analysts giving stock ratings to AXD2 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
AXD2 EPS for the last quarter is −0.02 CHF despite the estimation of −0.07 CHF. In the next quarter EPS is expected to reach −0.04 CHF. Track more of HERON THERAPEUTICS financials and stay on top of what is up with the company.
In the next quarter HERON THERAPEUTICS revenue is expected to reach 32.78 M CHF. Check out HERON THERAPEUTICS revenue and earnings and make informed decisions.
According to analysts, AXD2 price target is 6.18 CHF with a max estimate of 8.24 CHF and a min estimate of 4.58 CHF. Check if this forecast comes true in a year, meanwhile watch HERON THERAPEUTICS stock price chart and keep track of the current situation with AXD2 news and stock market news.